Additional file 8: Supplemental Table 1. The basic information of 20 NSCLC patients for LINC00173.v1 RT-qPCR analysis. Supplemental Table 2. The basic information of 43 patients with benign lung disease for LINC00173.v1 in situ hybridization analysis. Supplemental Table 3. The basic information of 396 patients with NSCLC for LINC00173.v1 in situ hybridization analysis. Supplemental Table 4. A list of primers used in the reactions for clone PCR. Supplemental Table 5. A list of primers used in the reactions for RT-qPCR. Supplemental Table 6. A list of primers used in the reactions for CHIP assay. Supplemental Table 7. The relationship between LINC00173.v1 expression level and clinical pathological characteristics in 396 patients with NSCLC. Supplemental Table 8. The relationship between LINC00173.v1 expression level and clinical pathological characteristics in 248 patients with lung SQC.